PATENT CLAIM ANALYSIS

Application Number: 15905249
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["800", "017000"]

Abstract:
The present invention is a porcine animal, tissue, organ, cells and cell lines, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha1,3GT). These animals, tissues, organs and cells can be used in xenotransplantation and for other medical purposes.

Claim (Index 1):
A method to select for cells lacking the cell surface epitope galactose alpha1,3-galactose comprising: (a) exposing a population of cells to  C. difficile  toxin A; (b) removing cells which are adversely affected by toxin A due to the receptor-mediated cytotoxicity of the toxin; and (c) expanding and maintaining a cell that does not show the effects of receptor-mediated cytotoxicity.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.225
- Patent Class: 800.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10646970', '11083393', '14449969', '10863116', '10981935']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5785919012744445
- 35 USC 102 Novelty (BERT): 0.5328819996328542
- Combined Prediction Score: 0.5740209111102854
- Mean Citation Score: 324.229998
- Max Citation Score: 384.98157
- Similarity Product: 259.51226017399733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test